The chemiluminescence immunoassay market is projected to reach $20.64B by 2029, driven by personalized medicine, AI integration, automated labs, and infectious disease diagnostics.
Read More
Global Emphysema market size is expected to reach $52.32 Billion by 2029 at 14.1%, rise in respiratory infections driving the growth of the market due to increasing disease progression
Read More
The cervical cancer screening market is projected to reach $11.18B by 2029, driven by HPV testing, AI colposcopy, self-sampling kits, and digital diagnostics.
Read More
Global Early Toxicity Testing market size is expected to reach $27.04 Billion by 2029 at 10.6%, growing focus on personalized medicine fueling the growth of the market due to demand for safer, tailored therapies
Read More
Global Dysthymia market size is expected to reach $5.76 Billion by 2029 at 6%, rising mental health disorders driving the growth of the market due to increasing stress and lifestyle pressures
Read More
The cell therapy processing market is projected to reach $8.73B by 2029, driven by automated technologies, AI integration, scalable therapies, and GMP-compliant systems.
Read More
Global Dyslipidemia market size is expected to reach $3.75 Billion by 2029 at 20.3%, rising obese population driving the growth of the market due to increasing metabolic disorders
Read More
The cell processing technologies market is projected to reach $8.15B by 2029, driven by personalized cell therapies, smart bioreactors, AI QC, and automated manufacturing.
Read More
Global Dupuytren’s Disease market size is expected to reach $8.54 Billion by 2029 at 9%, rising minimally invasive treatments fueling the growth of the market due to faster recovery and reduced complications
Read More
Global Dermatomycoses market size is expected to reach $378.28 Billion by 2029 at 8.6%, increasing prevalence of fungal infections fueling the growth of the market due to rising immunocompromised population and poor hygiene
Read More